News and Trends 7 May 2025
Top biotech deals of April 2025
Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery.
News and Trends
- Latest Posts
News and Trends 28 Apr 2025
U.S. budget cuts: what is the impact on therapeutic research?
We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits.
News and Trends 16 Apr 2025
Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases
Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.
News and Trends 15 Apr 2025
The AI race in biotech: Is Europe falling behind the US and China?
Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.
News and Trends 9 Apr 2025
The biotech job market in 2025: Still in survival mode?
The biotech job market has been tough the last few years but is it getting better? Delve into the industry’s job market in 2025.
News and Trends 4 Apr 2025
Developing drugs from outer space: Exobiosphere raises €2 million
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 2 Apr 2025
Top biotech deals of March 2025
Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations.
News and Trends 31 Mar 2025
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals.
News and Trends 25 Mar 2025
AbbVie and Genmab: Can a legal battle break a billion-dollar bond?
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.
News and Trends 24 Mar 2025
First-ever RIPTAC enters clinic: all you need to know about this new cancer approach
The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.
News and Trends 21 Mar 2025
Depression drug trials are failing—and placebos are to blame
In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.
News and Trends 10 Mar 2025
23andMe: the collapse of a genomics giant
23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?
ADVERTISEMENT
